A research team led by scientists from City University of Hong Kong (CityU) has achieved a significant breakthrough by inventing a new class of near-infrared-activated photo-oxidants that can effectively kill cancer cells ...
Sep 20, 2023
0
36
Hyperdiploidy is a genetic condition observed in cancer cells, where the cells contain more chromosomes than usual. The condition is particularly prevalent in childhood B-cell acute lymphoblastic leukemia (B-ALL), the most ...
Sep 20, 2023
0
1
Researchers at the University of Arizona Cancer Center discovered a new class of iron-targeting compounds that hamper the proliferation of cultured malignant cells in a laboratory setting. The results of the study were published ...
Sep 11, 2023
0
50
Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of immunotherapies against ...
Jul 31, 2023
0
33
Since the discovery of hallmark features of senescence such as cell cycle arrest, apoptosis resistance and development of a senescence-associated secretory phenotype (SASP), efforts in understanding how senescent cells drive ...
Jul 31, 2023
0
14
While photoactivated chemotherapy has received significant attention, the capacity to eradicate a deep tumor by using an external source that provides high penetration depth of tissue remains challenging. In a new report ...
A research team led by New Biology Professor Minseok Kim at the DGIST has developed a natural killer (NK) cell therapy product, which can self-activate with CT Cells. This new product has overcome the drawbacks of existing ...
Jul 5, 2023
0
2
Cancer remains one of the leading causes of death worldwide. Researchers are constantly looking for new therapies with improved anticancer activity, fewer side effects, and lower costs. In recent years, interest in bacterial ...
May 8, 2023
0
92
Medication delivered by a novel gel cured 100% of mice with an aggressive brain cancer, a striking result that offers new hope for patients diagnosed with glioblastoma, one of the deadliest and most common brain tumors in ...
Apr 24, 2023
0
62
A new research paper was published in Oncotarget, titled, "Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines."
Mar 28, 2023
0
5
